Assessment of major risk factors among stroke patients

Saudi Medical Journal

Volumn 31, Issue 9, 2010, Pages 1028-1031

  Awad, Sami M ^a   Al Jumaily, Hamoodi F ^a   Al Dulaimi, Khalid M ^a   Abdulghafoor, Raid H ^a  

^a UNIVERSITY OF ANBAR   (Iraq)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; CIGARETTE SMOKING; CLINICAL ARTICLE; COMPUTER ASSISTED TOMOGRAPHY; DIABETES MELLITUS; FEMALE; HEART ATRIUM FIBRILLATION; HEART FAILURE; HEART VENTRICLE ANEURYSM; HUMAN; HYPERTENSION; IRAQ; ISCHEMIC HEART DISEASE; LABORATORY TEST; MALE; MEDICAL INFORMATION; NEUROLOGIC EXAMINATION; RISK ASSESSMENT; RISK FACTOR; STROKE;

ADULT; AGE FACTORS; AGED; AGED, 80 AND OVER; CROSS-SECTIONAL STUDIES; DIABETES COMPLICATIONS; FEMALE; HUMANS; HYPERTENSION; IRAQ; MALE; MIDDLE AGED; RISK FACTORS; SEX FACTORS; SMOKING; STROKE;

EID: 77958510389     PISSN: 03795284     EISSN: 16583175     Source Type: Journal    
DOI: None     Document Type: Article

References (17)

1. Zivin JA. Approach to cerebrovascular disease. In: Goldman L, Ausiello DA, editors. Cecil Textbook of Medicine. 23rd ed. Philadelphia (PA): Saunders; 2007. p. 2701-2705.
2. Goldstein LB, Simel DL: Is this patient having a stroke? JAMA 2005; 239: 2391-2402.
3. Johnston SC. Clinical Practice. Transient Ischemic Attack. N Engl J Med 2002; 347: 1687-1692.
4. Allen CMC, Lueck CJ, Dennis M. Neurological disease. In: Boon NA, Colledge NR, Walker BR, Hunter JAA, editors. Davidson's Principles and Practice of Medicine. 20th ed. Edinburgh (UK): Churchill Livingstone; 2006: p. 1145-1254.
5. Counihan TJ. Cerebrovascular Disease. In: Andreoli TE, Carpenter CCJ, Griggs RC, Benjamin I, editors. Andreoli and Carpenter's Cecil Essentials of Medicine. 7th ed. Philadelphia (PA): Saunders; 2007. p. 1104-1115.
6. van der Worp HB, van Gijn J. Clinical practice. Acute ischemic stroke. N Engl J Med 2007; 357: 572-579.
7. Keaney JF Jr, Vita JA. Te value of infammation for predicting unstable angina. N Engl J Med 2002; 347: 55-57.
8. Paciaroni M, Agnelli G, Micheli S, Caso V. Efficacy and safety of anticoagulant treatment in acute cardioembolic stroke: a meta-analysis of randomized controlled trials. Stroke 2007; 38: 423-430.
9. Khaja AM, Grotta JC. Established treatments for acute ischemic stroke. Lancet 2007; 396: 319-330.
10. Yaggi HK, Concato J, Kernan WN, Lichtman JH, Brass LM, Mohsenin V. Obstructive sleep apnea as a risk factor for stroke and death. N Engl J Med 2005; 353: 2034-2041.
11. European Stroke Organisation (ESO) Executive Committee; ESO Writing Committee. Guidelines for management of ischaemic stroke and transient ischaemic attack 2008. Cerebrovasc Dis 2008; 25: 457-507.
12. Te Stroke prevention by Aggressive Reduction in Cholestrol Level (SPARCL) investigators. High-dose atorvastatin after stroke or transient ischemic attack. N Engl J Med 2006; 355: 549-559.
13. Ikram MA, Seshadri S, Bis JC, Fornage M, DeStefano AL, Aulchenko YS, et al. Genomewide association studies of stroke. N Engl J Med 2009; 360: 1718-1728.
14. Goldstein LB, Adams R, Alberts MJ, Appel LJ, Brass LM, Bushnell CD, et al. Primary prevention of ischemic stroke: a guideline from the American Heart Association/American Stroke Association Stroke Council. Circulation 2006; 113: e873-e923.
15. Kwan J. Clinical Epidemiology of Stroke. CME Journal Geriatric Medicine 2001; 3: 94-98.
16. Masoud SA. A survey on the prevalence of stroke risk factors in CVA diagnosed patients hospitalized in Shahid Beheshti. Hospital in 1998. Iranian Journal of Public Health 2002; 31: 21-22.
17. Yalcin E, Ylacin M, Celik Y, Topaloglu P, Iden M. Risk Factors for Recurrent Ischemic Stroke in Turkey. Medical Journal of Trakya University 2008; 25: 117-123.